A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
Clinical trial NCT04771273 · COMPLETED
Trial details
- NCT number
- NCT04771273
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2023-11-09
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.